Literature DB >> 12071702

Expression and purification of two hydrophobic double-spanning membrane proteins derived from the cystic fibrosis transmembrane conductance regulator.

Alex G Therien1, Mira Glibowicka, Charles M Deber.   

Abstract

We describe a rapid method for the expression and purification of two hydrophobic protein constructs derived from the membrane domain of the cystic fibrosis transmembrane conductance regulator (CFTR), the protein associated with cystic fibrosis. The proteins have no sequence homology but are both predicted to contain two membrane-spanning segments. The protocol involves the expression of CFTR constructs as thioredoxin fusion proteins in Escherichia coli, followed by partial purification by affinity chromatography, removal of the thioredoxin moiety by proteolytic cleavage in the presence of detergent, and final purification by reversed-phase high-performance liquid chromatography. The method yields milligram amounts of purified constructs that spontaneously insert into detergent micelles in alpha-helical conformation. We predict that this protocol will be applicable to a variety of proteins of similar size and hydrophobicity. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071702     DOI: 10.1006/prep.2001.1612

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  12 in total

1.  Specific binding of D1 protein degradation products to the psbAI promoter in Synechococcus sp. strain PCC 7942.

Authors:  Christian Stelljes; Friederike Koenig
Journal:  J Bacteriol       Date:  2006-12-22       Impact factor: 3.490

Review 2.  Making the most of fusion tags technology in structural characterization of membrane proteins.

Authors:  Hao Xie; Xiao-Ming Guo; Hong Chen
Journal:  Mol Biotechnol       Date:  2009-02-07       Impact factor: 2.695

3.  Membrane Protein Production and Purification from Escherichia coli and Sf9 Insect Cells.

Authors:  Yixin Liu; Ana Pavić; Joshua T Farley; Carine de Marcos Lousa; Adrian Goldman; Vincent L G Postis
Journal:  Methods Mol Biol       Date:  2020

4.  Detergent binding explains anomalous SDS-PAGE migration of membrane proteins.

Authors:  Arianna Rath; Mira Glibowicka; Vincent G Nadeau; Gong Chen; Charles M Deber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

5.  Large multiple transmembrane domain fragments of a G protein-coupled receptor: biosynthesis, purification, and biophysical studies.

Authors:  Zhanna Potetinova; Subramanyam Tantry; Leah S Cohen; Katrina E Caroccia; Boris Arshava; Jeffrey M Becker; Fred Naider
Journal:  Biopolymers       Date:  2012       Impact factor: 2.505

6.  A Modified Alderman-Grant Coil makes possible an efficient cross-coil probe for high field solid-state NMR of lossy biological samples.

Authors:  Christopher V Grant; Yuan Yang; Mira Glibowicka; Chin H Wu; Sang Ho Park; Charles M Deber; Stanley J Opella
Journal:  J Magn Reson       Date:  2009-08-15       Impact factor: 2.229

7.  Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326)).

Authors:  Yuxun Zhang; Xiang-Qun Xie
Journal:  Protein Expr Purif       Date:  2008-03-07       Impact factor: 1.650

Review 8.  Crystal structures of fusion proteins with large-affinity tags.

Authors:  Douglas R Smyth; Marek K Mrozkiewicz; William J McGrath; Pawel Listwan; Bostjan Kobe
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

9.  CFTR transmembrane segments are impaired in their conformational adaptability by a pathogenic loop mutation and dynamically stabilized by Lumacaftor.

Authors:  Georg Krainer; Mathias Schenkel; Andreas Hartmann; Dorna Ravamehr-Lake; Charles M Deber; Michael Schlierf
Journal:  J Biol Chem       Date:  2019-12-27       Impact factor: 5.157

10.  Application of DETECTER, an evolutionary genomic tool to analyze genetic variation, to the cystic fibrosis gene family.

Authors:  Eric A Gaucher; Danny W De Kee; Steven A Benner
Journal:  BMC Genomics       Date:  2006-03-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.